Beckman Coulter Life Sciences prend des mesures dans le meilleur intérêt de nos associés, clients et partenaires commerciaux alors que nous naviguons contre les menaces croissantes de la maladie du nouveau coronavirus 2019 (COVID-19).
Researchers are hoping to tap into the potential of small particles as indicators in cancers and other diseases, communication channels, drug delivery mechanisms, and more. We explore particles that fall between 80 nm and 1 micron, how our instruments enable your small particle research, and exciting developments and discoveries in the biological nanoparticle research world.
